EGFR and non-small cell lung carcinoma: In 1089 Chinese NSCLC patients, 52.41% of TTF-1-positive patients were accompanied by EGFR mutation, while only 14.66% of TTF-1-negative patients were with mutation (p < 0.001) [9].